Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Givosiran, for the Treatment of Acute Hepatic Porphyria Transcript - Thomson StreetEvents

Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Givosiran, for the Treatment of Acute Hepatic Porphyria Transcript

Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Givosiran, for the Treatment of Acute Hepatic Porphyria Transcript - Thomson StreetEvents
Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Givosiran, for the Treatment of Acute Hepatic Porphyria Transcript
Published Aug 04, 2021
Published Aug 04, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ALNY.OQ conference call or presentation 4-Aug-21 5:30pm GMT

  
Report Type:

Transcript

Source:
Company:
Alnylam Pharmaceuticals Inc
Ticker
ALNY.OQ
Time
5:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Liver-Directed RNAi Pipeline Programs Transcript – 2021-09-20 – US$ 54.00 – Edited Transcript of ALNY.OQ conference call or presentation 20-Sep-21 3:00pm GMT

Alnylam Pharmaceuticals Inc at Bank of America Global Healthcare Conference (Virtual) Transcript – 2021-09-16 – US$ 54.00 – Edited Transcript of ALNY.OQ presentation 16-Sep-21 2:05pm GMT

Alnylam Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) Transcript – 2021-09-13 – US$ 54.00 – Edited Transcript of ALNY.OQ presentation 13-Sep-21 11:00am GMT

Alnylam Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2021-09-09 – US$ 54.00 – Edited Transcript of ALNY.OQ presentation 9-Sep-21 7:30pm GMT

Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Lumasiran, for the Treatment of Primary Hyperoxaluria Type 1 Transcript – 2021-08-19 – US$ 54.00 – Edited Transcript of ALNY.OQ conference call or presentation 19-Aug-21 1:30pm GMT

Alnylam Pharmaceuticals Inc Q2 2021 Earnings Call Summary – 2021-08-03 – US$ 54.00 – Edited Brief of ALNY.OQ earnings conference call or presentation 3-Aug-21 12:30pm GMT

Alnylam Pharmaceuticals Inc Q2 2021 Earnings Call Transcript – 2021-08-03 – US$ 54.00 – Edited Transcript of ALNY.OQ earnings conference call or presentation 3-Aug-21 12:30pm GMT

Alnylam Pharmaceuticals Inc "RNAi Roundtable" Webcast Series: Patisiran & Vutrisiran, in Development for the Treatment of ATTR Amyloidosis Transcript – 2021-07-16 – US$ 54.00 – Edited Transcript of ALNY.OQ conference call or presentation 16-Jul-21 3:00pm GMT

Alnylam Pharmaceuticals Inc "RNAi Roundtable” Webcast Series: ALN-AGT, in Development for the Treatment of Hypertension Transcript – 2021-06-30 – US$ 54.00 – Edited Transcript of ALNY.OQ conference call or presentation 30-Jun-21 2:00pm GMT

Alnylam Pharmaceuticals Inc at Nasdaq Investor Conference (Virtual) Transcript – 2021-06-15 – US$ 54.00 – Edited Transcript of ALNY.OQ presentation 15-Jun-21 2:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Givosiran, for the Treatment of Acute Hepatic Porphyria Transcript" Aug 04, 2021. Alacra Store. May 04, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Alnylam-Pharmaceuticals-Inc-RNAi-Roundtable-Webcast-Series-Givosiran-for-the-Treatment-of-Acute-Hepatic-Porphyria-T14899418>
  
APA:
Thomson StreetEvents. (2021). Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Givosiran, for the Treatment of Acute Hepatic Porphyria Transcript Aug 04, 2021. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Alnylam-Pharmaceuticals-Inc-RNAi-Roundtable-Webcast-Series-Givosiran-for-the-Treatment-of-Acute-Hepatic-Porphyria-T14899418>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.